Giant Biogene Holding Co. Ltd. Financial Overview
Giant Biogene Holding Co. Ltd.'s market cap is currently HK$37.52B. The company's EPS TTM is HK$1.2372294403; its P/E ratio is 14.91; and it has a dividend yield of 1.86%. Giant Biogene Holding Co. Ltd. is scheduled to report earnings on August 27, 2025, and the estimated EPS forecast is HK$1.25. See an overview of income statement, balance sheet, and cash flow financials.
